Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study of Linaclotide in patients with colorectal adenoma and colorectal cancer (stages 0–III), currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linaclotide (linaclotide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Colorectal Adenoma, Stage 0 Colorectal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING